A detailed history of Legal & General Group PLC transactions in Medtronic PLC stock. As of the latest transaction made, Legal & General Group PLC holds 11,697,691 shares of MDT stock, worth $948 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
11,697,691
Previous 11,697,691 -0.0%
Holding current value
$948 Million
Previous $1.05 Billion -0.0%
% of portfolio
0.22%
Previous 0.22%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.84 - $91.03 $7.25 Million - $8.59 Million
94,374 Added 0.81%
11,697,691 $1.05 Billion
Q2 2024

Aug 14, 2024

SELL
$78.71 - $87.02 $6.54 Million - $7.23 Million
-83,060 Reduced 0.71%
11,603,317 $913 Million
Q1 2024

May 14, 2024

SELL
$82.84 - $88.09 $8.5 Million - $9.04 Million
-102,638 Reduced 0.87%
11,686,377 $1.02 Billion
Q4 2023

Feb 15, 2024

BUY
$69.43 - $83.43 $130 Million - $157 Million
1,876,040 Added 18.93%
11,789,015 $971 Million
Q3 2023

Nov 14, 2023

SELL
$78.22 - $90.4 $23.6 Million - $27.2 Million
-301,404 Reduced 2.95%
9,912,975 $777 Million
Q2 2023

Aug 14, 2023

BUY
$79.47 - $91.38 $41.2 Million - $47.4 Million
518,483 Added 5.35%
10,214,379 $900 Million
Q1 2023

May 15, 2023

BUY
$76.72 - $87.58 $5.49 Million - $6.27 Million
71,558 Added 0.74%
9,695,896 $782 Million
Q4 2022

Feb 14, 2023

SELL
$76.18 - $87.74 $34.6 Million - $39.8 Million
-453,649 Reduced 4.5%
9,624,338 $748 Million
Q3 2022

Nov 14, 2022

SELL
$80.75 - $95.31 $26.1 Million - $30.8 Million
-322,973 Reduced 3.11%
10,077,987 $814 Million
Q2 2022

Aug 22, 2022

BUY
$87.4 - $113.09 $25.6 Million - $33.1 Million
292,575 Added 2.89%
10,400,960 $933 Million
Q1 2022

May 16, 2022

BUY
$100.58 - $112.38 $70.4 Million - $78.7 Million
700,092 Added 7.44%
10,108,385 $1.12 Billion
Q4 2021

Feb 14, 2022

SELL
$99.53 - $127.75 $30.2 Million - $38.8 Million
-303,715 Reduced 3.13%
9,408,293 $973 Million
Q3 2021

Nov 15, 2021

BUY
$122.75 - $135.17 $49.2 Million - $54.1 Million
400,444 Added 4.3%
9,712,008 $1.22 Billion
Q2 2021

Aug 12, 2021

BUY
$118.19 - $131.5 $39.7 Million - $44.1 Million
335,638 Added 3.74%
9,311,564 $1.16 Billion
Q1 2021

May 17, 2021

SELL
$111.18 - $119.74 $20.1 Million - $21.7 Million
-180,970 Reduced 1.98%
8,975,926 $1.06 Billion
Q4 2020

Feb 12, 2021

BUY
$100.57 - $117.14 $1.92 Million - $2.24 Million
19,121 Added 0.21%
9,156,896 $1.07 Billion
Q3 2020

Nov 13, 2020

SELL
$90.13 - $108.78 $12.7 Million - $15.3 Million
-140,607 Reduced 1.52%
9,137,775 $949 Million
Q2 2020

Aug 14, 2020

SELL
$84.11 - $103.33 $7.82 Million - $9.61 Million
-93,012 Reduced 0.99%
9,278,382 $851 Million
Q1 2020

May 14, 2020

BUY
$72.92 - $121.3 $22.3 Million - $37.1 Million
305,954 Added 3.37%
9,371,394 $846 Million
Q4 2019

Feb 13, 2020

BUY
$104.49 - $114.54 $14.1 Million - $15.4 Million
134,770 Added 1.51%
9,065,440 $1.03 Billion
Q3 2019

Nov 13, 2019

SELL
$98.02 - $111.18 $2.61 Million - $2.97 Million
-26,678 Reduced 0.3%
8,930,670 $970 Million
Q2 2019

Aug 14, 2019

SELL
$84.15 - $99.38 $1.25 Million - $1.47 Million
-14,828 Reduced 0.17%
8,957,348 $872 Million
Q1 2019

May 15, 2019

BUY
$82.45 - $93.79 $132 Million - $151 Million
1,605,788 Added 21.8%
8,972,176 $817 Million
Q4 2018

Feb 15, 2019

BUY
$85.8 - $99.49 $37.8 Million - $43.8 Million
440,229 Added 6.36%
7,366,388 $670 Million
Q3 2018

Nov 20, 2018

BUY
$85.91 - $99.17 $8.73 Million - $10.1 Million
101,574 Added 1.49%
6,926,159 $681 Million
Q2 2018

Aug 10, 2018

SELL
$77.48 - $87.83 $17.5 Million - $19.8 Million
-225,864 Reduced 3.2%
6,824,585 $585 Million
Q1 2018

May 17, 2018

BUY
$76.55 - $87.26 $6.02 Million - $6.86 Million
78,638 Added 1.13%
7,050,449 $565 Million
Q4 2017

Feb 13, 2018

BUY
$76.93 - $83.5 $536 Million - $582 Million
6,971,811
6,971,811 $563 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.